In this Gemini video overview, we will look at a newly published study examining nicotinamide mononucleotide (NMN) as a neuroprotective treatment after spinal cord injury (SCI) in mice. NMN restores cellular NAD+ levels, which fall after trauma, and reduces inflammation by regulating the NF-κB pathway. Histological and behavioural assessments show preserved nerve tissue, fewer cavities, and improved locomotor recovery and motor function.
显示更多